Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

474 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adherence to recommendations of the Therapeutic Positioning Report about treatment with oral anticoagulants in elderly patients with atrial fibrillation. The ESPARTA study.
Suárez Fernández C, Mostaza JM, Castilla Guerra L, Cantero Hinojosa J, Suriñach JM, Acosta de Bilbao F, Tamarit JJ, Diaz Diaz JL, Hernandez JL, Cazorla D, Ràfols C; en nombre de los Investigadores del Estudio ESPARTA. Suárez Fernández C, et al. Among authors: hernandez jl. Med Clin (Barc). 2018 Jul 13;151(1):8-15. doi: 10.1016/j.medcli.2017.07.025. Epub 2017 Oct 6. Med Clin (Barc). 2018. PMID: 28992980 English, Spanish.
Satisfaction with oral anticoagulants in patients with atrial fibrillation.
Suárez Fernández C, Castilla-Guerra L, Cantero Hinojosa J, Suriñach JM, Acosta de Bilbao F, Tamarit JJ, Diaz Diaz JL, Hernandez JL, Pose A, Montero-Pérez-Barquero M, Roquer J, Gállego J, Vivancos J, Mostaza JM. Suárez Fernández C, et al. Among authors: hernandez jl. Patient Prefer Adherence. 2018 Feb 19;12:267-274. doi: 10.2147/PPA.S152109. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 29497282 Free PMC article.
Role of rivaroxaban in the prevention of atherosclerotic events.
Sanmartín M, Bellmunt S, Cosín-Sales J, García-Moll X, Riera-Mestre A, Almendro-Delia M, Hernández JL, Lozano F, Mazón P, Suarez Fernández C. Sanmartín M, et al. Among authors: hernandez jl. Expert Rev Clin Pharmacol. 2019 Aug;12(8):771-780. doi: 10.1080/17512433.2019.1637732. Epub 2019 Jul 9. Expert Rev Clin Pharmacol. 2019. PMID: 31269825 Review.
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition.
González-Juanatey JR, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Gómez-Doblas JJ, Riambau V, García-Moll X, García-Alegría J, Hernández JL, Lozano FS, Suarez Fernández C. González-Juanatey JR, et al. Among authors: hernandez jl. Expert Rev Clin Pharmacol. 2020 Jul;13(7):695-706. doi: 10.1080/17512433.2020.1772056. Expert Rev Clin Pharmacol. 2020. PMID: 32434452 Review.
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial.
Hernández JL, Lozano FS, Riambau V, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Garcia-Alegria J, Garcia-Moll X, Gomez-Doblas JJ, Gonzalez-Juanatey JR, Suarez Fernández C. Hernández JL, et al. Drugs Context. 2020 Jul 6;9:2020-5-5. doi: 10.7573/dic.2020-5-5. eCollection 2020. Drugs Context. 2020. PMID: 32699549 Free PMC article. Review.
Strategies to improve cardiovascular health and treatment of dyslipidemia in Spain. Expert Insights Project.
Pedro-Botet J, Freixa R, Tamarit JJ, López-Miranda J, Fernández-Olmo R, Muñiz-Grijalvo O, Vázquez-García R, Guijarro C, Rodríguez-Padial L, Díaz-Díaz JL, Bravo-Amaro M, Hernández JL, Alarcón-Duque JA, Martin-Armas JA, García-López M, Cosín-Sales J. Pedro-Botet J, et al. Among authors: hernandez jl. Clin Investig Arterioscler. 2024 Sep 19:S0214-9168(24)00087-1. doi: 10.1016/j.arteri.2024.08.007. Online ahead of print. Clin Investig Arterioscler. 2024. PMID: 39304407 English, Spanish.
Clinical profile of patients treated with evolocumab in lipid/internal medicine units of Spain. Observational study (RETOSS-IMU).
Masana L, López Miranda J, Civeira F, Reinares L, Guijarro C, Plana N, Cuenca R, Sánchez D, Hernández JL, Andrés R, Blanco A, Villamayor S. Masana L, et al. Among authors: hernandez jl. Clin Investig Arterioscler. 2020 Sep-Oct;32(5):183-192. doi: 10.1016/j.arteri.2020.02.003. Epub 2020 Apr 18. Clin Investig Arterioscler. 2020. PMID: 32317124 Free article. English, Spanish.
Left-sided infective endocarditis in patients with liver cirrhosis.
Ruiz-Morales J, Ivanova-Georgieva R, Fernández-Hidalgo N, García-Cabrera E, Miró JM, Muñoz P, Almirante B, Plata-Ciézar A, González-Ramallo V, Gálvez-Acebal J, Fariñas MC, Bravo-Ferrer JM, Goenaga-Sánchez MA, Hidalgo-Tenorio C, Goikoetxea-Agirre J, de Alarcón-González A; Spanish Collaboration on Endocarditis Group-Grupo de Apoyo al Manejo de la Endocarditis en España (GAMES); Spanish Network for Research in Infectious Diseases (REIPI). Ruiz-Morales J, et al. J Infect. 2015 Dec;71(6):627-41. doi: 10.1016/j.jinf.2015.09.005. Epub 2015 Sep 25. J Infect. 2015. PMID: 26408206
Valve surgery in active infective endocarditis: a simple score to predict in-hospital prognosis.
Martínez-Sellés M, Muñoz P, Arnáiz A, Moreno M, Gálvez J, Rodríguez-Roda J, de Alarcón A, García Cabrera E, Fariñas MC, Miró JM, Montejo M, Moreno A, Ruiz-Morales J, Goenaga MA, Bouza E; Spanish Collaboration on Endocarditis — Grupo de Apoyo al Manejo de la Endocarditis infecciosa en ESpaña (GAMES). Martínez-Sellés M, et al. Int J Cardiol. 2014 Jul 15;175(1):133-7. doi: 10.1016/j.ijcard.2014.04.266. Epub 2014 May 9. Int J Cardiol. 2014. PMID: 24852838
474 results